Fresenius Medical Care made a net profit of EUR 1,982 mil with revenues of EUR 16,547 mil in 2018, up by 54.9% and down by 6.95%, respectively, compared to the previous year. This translates into a net margin of 12.0%.
On the operating level, EBITDA reached EUR 2,880 mil, down 1.05% compared to the previous year. Over the last five years, the company's EBITDA has risen 5.9% a year on average.
The company generated cash, defined by a sum of net profit and depreciation, of EUR 2,707 mil or 16.4% of sales. When investments are excluded, free cash flow reached EUR 1,005 mil, or 6.07% of sales in 2018.
In the last five years, the company generated free cash flow of EUR 4,864 mil. That compares to a cumulative net profit of EUR 6,102 mil in the same period.
You can see all the company’s data at Fresenius Medical Care profile, or you can download a report on the company in the report section.
Helgi Library 
